220 related articles for article (PubMed ID: 25557218)
1. Isolevuglandin adducts in disease.
Salomon RG; Bi W
Antioxid Redox Signal; 2015 Jun; 22(18):1703-18. PubMed ID: 25557218
[TBL] [Abstract][Full Text] [Related]
2. Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro.
Poliakov E; Meer SG; Roy SC; Mesaros C; Salomon RG
Chem Res Toxicol; 2004 May; 17(5):613-22. PubMed ID: 15144218
[TBL] [Abstract][Full Text] [Related]
3. Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts.
Guo L; Chen Z; Amarnath V; Yancey PG; Van Lenten BJ; Savage JR; Fazio S; Linton MF; Davies SS
Antioxid Redox Signal; 2015 Jun; 22(18):1633-45. PubMed ID: 25751734
[TBL] [Abstract][Full Text] [Related]
4. Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo.
Poliakov E; Brennan ML; Macpherson J; Zhang R; Sha W; Narine L; Salomon RG; Hazen SL
FASEB J; 2003 Dec; 17(15):2209-20. PubMed ID: 14656983
[TBL] [Abstract][Full Text] [Related]
5. Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.
Li W; Laird JM; Lu L; Roychowdhury S; Nagy LE; Zhou R; Crabb JW; Salomon RG
Free Radic Biol Med; 2009 Dec; 47(11):1539-52. PubMed ID: 19751823
[TBL] [Abstract][Full Text] [Related]
6. Generation and detection of levuglandins and isolevuglandins in vitro and in vivo.
Zhang M; Li W; Li T
Molecules; 2011 Jun; 16(7):5333-48. PubMed ID: 21705973
[TBL] [Abstract][Full Text] [Related]
7. Levuglandins and isolevuglandins: stealthy toxins of oxidative injury.
Salomon RG
Antioxid Redox Signal; 2005; 7(1-2):185-201. PubMed ID: 15650407
[TBL] [Abstract][Full Text] [Related]
8. Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases.
Aschner M; Nguyen TT; Sinitskii AI; Santamaría A; Bornhorst J; Ajsuvakova OP; da Rocha JBT; Skalny AV; Tinkov AA
Free Radic Biol Med; 2021 Jan; 162():266-273. PubMed ID: 33099003
[TBL] [Abstract][Full Text] [Related]
9. Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway.
Salomon RG; Batyreva E; Kaur K; Sprecher DL; Schreiber MJ; Crabb JW; Penn MS; DiCorletoe AM; Hazen SL; Podrez EA
Biochim Biophys Acta; 2000 May; 1485(2-3):225-35. PubMed ID: 10832102
[TBL] [Abstract][Full Text] [Related]
10. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.
Roberts LJ; Salomon RG; Morrow JD; Brame CJ
FASEB J; 1999 Jul; 13(10):1157-68. PubMed ID: 10385607
[TBL] [Abstract][Full Text] [Related]
11. Molecular Structures of Isolevuglandin-Protein Cross-Links.
Bi W; Jang GF; Zhang L; Crabb JW; Laird J; Linetsky M; Salomon RG
Chem Res Toxicol; 2016 Oct; 29(10):1628-1640. PubMed ID: 27599534
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways.
Salomon RG
Chem Phys Lipids; 2005 Mar; 134(1):1-20. PubMed ID: 15752459
[TBL] [Abstract][Full Text] [Related]
13. Oxidized phospholipids, isolevuglandins, and atherosclerosis.
Zhang W; Salomon RG
Mol Nutr Food Res; 2005 Nov; 49(11):1050-62. PubMed ID: 16270278
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry detection of isolevuglandin adduction to specific protein residues.
Charvet CD; Pikuleva IA
Methods Mol Biol; 2015; 1208():285-98. PubMed ID: 25323515
[TBL] [Abstract][Full Text] [Related]
15. Posttranslational modification by an isolevuglandin diminishes activity of the mitochondrial cytochrome P450 27A1.
Charvet CD; Laird J; Xu Y; Salomon RG; Pikuleva IA
J Lipid Res; 2013 May; 54(5):1421-9. PubMed ID: 23479405
[TBL] [Abstract][Full Text] [Related]
16. The Adductomics of Isolevuglandins: Oxidation of IsoLG Pyrrole Intermediates Generates Pyrrole⁻Pyrrole Crosslinks and Lactams.
Bi W; Jang GF; Zhang L; Crabb JW; Laird J; Linetsky M; Salomon RG
High Throughput; 2019 May; 8(2):. PubMed ID: 31083423
[TBL] [Abstract][Full Text] [Related]
17. Targeting of reactive isolevuglandins in mitochondrial dysfunction and inflammation.
Mayorov V; Uchakin P; Amarnath V; Panov AV; Bridges CC; Uzhachenko R; Zackert B; Moore CS; Davies S; Dikalova A; Dikalov S
Redox Biol; 2019 Sep; 26():101300. PubMed ID: 31437812
[TBL] [Abstract][Full Text] [Related]
18. Isolevuglandins as a gauge of lipid peroxidation in human tumors.
Yan HP; Roberts LJ; Davies SS; Pohlmann P; Parl FF; Estes S; Maeng J; Parker B; Mernaugh R
Free Radic Biol Med; 2017 May; 106():62-68. PubMed ID: 28189846
[TBL] [Abstract][Full Text] [Related]
19. Isolevuglandin-modified phosphatidylethanolamine is metabolized by NAPE-hydrolyzing phospholipase D.
Guo L; Gragg SD; Chen Z; Zhang Y; Amarnath V; Davies SS
J Lipid Res; 2013 Nov; 54(11):3151-7. PubMed ID: 24018423
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with pyridoxamine mitigates isolevuglandin-associated retinal effects in mice exposed to bright light.
Charvet CD; Saadane A; Wang M; Salomon RG; Brunengraber H; Turko IV; Pikuleva IA
J Biol Chem; 2013 Oct; 288(41):29267-80. PubMed ID: 23970548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]